Lv1
5 积分 2021-07-05 加入
Current developments in gastric cancer: from molecular profiling to treatment strategy
1个月前
已完结
Gastric cancer treatment: recent progress and future perspectives
1个月前
已完结
Gastric cancer treatment: recent progress and future perspectives
1个月前
已完结
Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial
2个月前
已完结
Colorectal cancer
2个月前
已完结
Mechanisms of metastatic colorectal cancer
2个月前
已完结
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
2个月前
已完结
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
2个月前
已完结
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
2个月前
已完结
Targeting angiogenesis in oncology, ophthalmology and beyond
2个月前
已完结
皖公网安备34019202002308
